Company Quick10K Filing
Regen Biopharma
10-Q 2019-06-30 Filed 2019-10-24
10-Q 2019-03-31 Filed 2019-08-29
10-Q 2018-12-31 Filed 2019-02-12
10-K 2018-09-30 Filed 2018-12-27
10-Q 2018-06-30 Filed 2018-08-06
10-Q 2018-03-31 Filed 2018-05-14
10-Q 2017-12-31 Filed 2018-02-06
10-K 2017-09-30 Filed 2018-01-05
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-05
10-Q 2016-12-31 Filed 2017-01-27
10-K 2016-09-30 Filed 2016-12-21
10-Q 2016-06-30 Filed 2016-08-01
10-Q 2016-03-31 Filed 2016-04-29
10-Q 2015-12-31 Filed 2016-01-28
10-K 2015-09-30 Filed 2016-01-07
10-Q 2015-06-30 Filed 2015-07-29
10-Q 2015-03-31 Filed 2015-05-07
10-Q 2014-12-31 Filed 2015-02-04
10-K 2014-09-30 Filed 2014-12-18
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-05
8-K 2020-01-20
8-K 2019-12-16
8-K 2019-12-13
8-K 2019-11-18
8-K 2019-08-14
8-K 2019-08-13
8-K 2019-08-13
8-K 2019-07-24
8-K 2019-07-19
8-K 2019-06-27
8-K 2019-05-08
8-K 2019-04-08
8-K 2019-03-13
8-K 2019-02-13
8-K 2019-01-22
8-K 2018-11-15
8-K 2018-10-11
8-K 2018-10-02
8-K 2018-09-30
8-K 2018-07-03
8-K 2018-01-10

Regen Biopharma Financials

RGBP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
Sunshine Biopharma (SBFM) 0 30% 0.1 -864% 146 889 130 38 -1,264 -1,160 -82
Pacific Ventures (PACV) 0 25% -3.8 -65% 1,799 5,073 3,514 883 -1,171 -615 2,318
Nate's Food (NHMD) 0 92% -0.1 -6,857% 7 825 3 3 -481 -455 30
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Life Clips (LCLP) 0 135% -0.7 -21,823% 16 9,270 -86 -116 -3,494 -3,182 2,355
YaSheng Group (HERB)
VNUE (VNUE) 0 0% -2.0 -621% 168 3,666 200 0 -1,042 -634 1,242
XsunX (XSNX) 0 47% 0.1 1,089% 215 2,451 1,609 753 2,344 2,417 194
New You (NWYU)
Galileo Acquisition (GLEO)
Anchiano Therapeutics (ANCN)
Regen Biopharma (RGBP) 0 0% -0.3 -4,777% 114 12,900 82 0 -5,461 -5,186 1,325
Nutra Pharma (NPHC) 0 71% -0.2 -2,939% 252 5,614 106 75 -7,398 -6,591 1,498
Sprout Social (SPT)
Force Protection Video Equipment (FPVD) 0 56% 0.0 -394% 204 583 216 120 -802 -829 -1
Gafisa (GFA)
United States Diesel-Heating Oil Fund (UHN) 0 0% -0.0 0 0 677 0 639 639 -0
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75

Balance Sheet ($'000)2013-06-302014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash41234905452220939169106140252211134022702623155839152
Accounts Receivable8383831030000001643
Inventory
PP&E
Assets41235211655352282203181932513197075989669441,14975755920918244114
Accounts Payable10341612628211482411644485544965623647481817995
Long-Term Debt90947951432493546467137757929421,327
Liabilities08571403261801453183404487529068632,0624,9846,1968,9509,5959,1349,3318,8468,86612,900
Stockholders' Equity4115-6-130-26135583-97-22-255-501-587-156-1,464-4,019-5,251-9,122-8,664-8,822-12,802
Income Statement ($'000)2013-06-302014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue000000192000100001100001000272727
Cost of Revenue
Gross Profit
R&D38022568189105172208185433653743685482469367115
SG&A72133128139315464407489435435306243198193188178220173173159127111
Tax
Net Income-75-186-166-195-219-8,813-1,562-601-1,857-1,090-2,357-2,377-2,525-1,390-2,622-1,252-2,785-1,132176-974248-332-4,403
Cash Flow ($'000)2013-06-302014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-1,836974-411-398-504-350-417-623-627-404-87-460-150-128-67
Cash Investing-168-190-197-8,580-1,573-6625000
Cash Financing951412519,0491,2604921,966-1,036445283700-1,6432,59149161917311241813110454